(BANK) Evolve Canadian Banks - Ratings and Ratios

Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA30053T1093

BANK: Canadian Banks, Lifecos, ETF, Alternative Equity

The Evolve Canadian Banks and Lifecos Enhanced Yield Index Fund, ticker symbol BANK, is an ETF that focuses on the Canadian banking and life insurance sectors, providing investors with a yield-enhanced index fund that tracks the performance of these financial institutions.

By leveraging the expertise of Evolve ETFs, BANK offers a unique investment opportunity that is grounded in the stability and profitability of Canadas major banks and life insurance companies. The funds underlying index is designed to provide a diversified portfolio of these financial institutions, allowing investors to tap into the Canadian financial sectors strength.

From a technical analysis perspective, BANKs price action indicates a bullish trend, with its short-term and long-term moving averages (SMA20: 7.50, SMA50: 7.49, SMA200: 7.30) suggesting a gradual upward momentum. The Average True Range (ATR: 0.16 = 2.04%) indicates moderate volatility, which may present trading opportunities. Given the current price (7.76) is near its 52-week high (7.81), a potential forecast is that BANK may continue to consolidate around this level before breaking out further, potentially reaching new highs.

Fundamentally, the AUM of 395.00M CAD indicates a respectable level of investor interest and confidence in the fund. Considering the Canadian banking sectors historical stability and the life insurance sectors steady demand, BANK is well-positioned to capitalize on these trends. As the Canadian financial sector continues to evolve, BANKs diversified portfolio is likely to remain resilient, potentially driving long-term growth.

Combining technical and fundamental insights, a potential forecast is that BANK may experience a moderate increase in value over the next quarter, driven by the ongoing stability of the Canadian financial sector and the funds diversified portfolio. If the current bullish trend continues, BANK may reach a price target of 8.00-8.20, representing a 3-5% increase from its current price.

Additional Sources for BANK ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BANK ETF Overview

Market Cap in USD 289m
Category Alternative Equity Focused
IPO / Inception 2022-02-01

BANK ETF Ratings

Growth Rating 43.9
Fundamental -
Dividend Rating 95.3
Rel. Strength 19.8
Analysts -
Fair Price Momentum 9.22 CAD
Fair Price DCF -

BANK Dividends

Dividend Yield 12m 16.65%
Yield on Cost 5y 20.16%
Annual Growth 5y 16.90%
Payout Consistency 100.0%
Payout Ratio %

BANK Growth Ratios

Growth Correlation 3m 81.7%
Growth Correlation 12m 81.6%
Growth Correlation 5y 74.3%
CAGR 5y 6.98%
CAGR/Max DD 5y 0.24
Sharpe Ratio 12m 3.05
Alpha 29.02
Beta 0.404
Volatility 9.56%
Current Volume 354.3k
Average Volume 20d 263.1k
What is the price of BANK shares?
As of June 14, 2025, the stock is trading at CAD 7.97 with a total of 354,348 shares traded.
Over the past week, the price has changed by -0.87%, over one month by +2.93%, over three months by +11.44% and over the past year by +35.37%.
Is Evolve Canadian Banks a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Evolve Canadian Banks (TO:BANK) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 43.91 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BANK is around 9.22 CAD . This means that BANK is currently undervalued and has a potential upside of +15.68% (Margin of Safety).
Is BANK a buy, sell or hold?
Evolve Canadian Banks has no consensus analysts rating.
What are the forecasts for BANK share price target?
According to our own proprietary Forecast Model, BANK Evolve Canadian Banks will be worth about 10.2 in June 2026. The stock is currently trading at 7.97. This means that the stock has a potential upside of +27.35%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 10.2 27.4%